AtriCure Statistics
Share Statistics
AtriCure has 49.5M
shares outstanding. The number of shares has increased by 1.03%
in one year.
| Shares Outstanding | 49.5M |
| Shares Change (YoY) | 1.03% |
| Shares Change (QoQ) | 0.26% |
| Owned by Institutions (%) | 98.59% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 92 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 1.56M, so 3.16% of the outstanding
shares have been sold short.
| Short Interest | 1.56M |
| Short % of Shares Out | 3.16% |
| Short % of Float | 3.27% |
| Short Ratio (days to cover) | 2.08 |
Valuation Ratios
The PE ratio is -32.11 and the forward
PE ratio is -97.51.
AtriCure's PEG ratio is
-0.73.
| PE Ratio | -32.11 |
| Forward PE | -97.51 |
| PS Ratio | 3.08 |
| Forward PS | 2 |
| PB Ratio | 3.11 |
| P/FCF Ratio | -127.52 |
| PEG Ratio | -0.73 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for AtriCure.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.65,
with a Debt / Equity ratio of 0.17.
| Current Ratio | 3.65 |
| Quick Ratio | 2.62 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | -4.13 |
| Debt / FCF | -6.8 |
| Interest Coverage | -6.25 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $357,928.46 |
| Profits Per Employee | $-34,383.08 |
| Employee Count | 1,300 |
| Asset Turnover | 0.76 |
| Inventory Turnover | 1.56 |
Taxes
| Income Tax | 1.02M |
| Effective Tax Rate | -2.34% |
Stock Price Statistics
The stock price has increased by 53.15% in the
last 52 weeks. The beta is 1.58, so AtriCure's
price volatility has been higher than the market average.
| Beta | 1.58 |
| 52-Week Price Change | 53.15% |
| 50-Day Moving Average | 32.49 |
| 200-Day Moving Average | 32.68 |
| Relative Strength Index (RSI) | 60.04 |
| Average Volume (20 Days) | 628,014 |
Income Statement
In the last 12 months, AtriCure had revenue of 465.31M
and earned -44.7M
in profits. Earnings per share was -0.95.
| Revenue | 465.31M |
| Gross Profit | 347.52M |
| Operating Income | -40.01M |
| Net Income | -44.7M |
| EBITDA | -18.53M |
| EBIT | -37.27M |
| Earnings Per Share (EPS) | -0.95 |
Full Income StatementBalance Sheet
The company has 122.72M in cash and 76.53M in
debt, giving a net cash position of 46.19M.
| Cash & Cash Equivalents | 122.72M |
| Total Debt | 76.53M |
| Net Cash | 46.19M |
| Retained Earnings | -401.75M |
| Total Assets | 591.63M |
| Working Capital | 190.26M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 12.2M
and capital expenditures -23.46M, giving a free cash flow of -11.26M.
| Operating Cash Flow | 12.2M |
| Capital Expenditures | -23.46M |
| Free Cash Flow | -11.26M |
| FCF Per Share | -0.24 |
Full Cash Flow StatementMargins
Gross margin is 74.69%, with operating and profit margins of -8.6% and -9.61%.
| Gross Margin | 74.69% |
| Operating Margin | -8.6% |
| Pretax Margin | -9.39% |
| Profit Margin | -9.61% |
| EBITDA Margin | -3.98% |
| EBIT Margin | -8.6% |
| FCF Margin | -2.42% |
